Laboratorios Farma | ROVI - 销售收入

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.04B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	销售	更改		日
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Almirall	EUR 602.71M		55.09M	2026-06
Avita Medical	AUD 17.61M		805K	2025-12
Dianthus Therapeutics	USD 463K		179K	2026-03
Ionis Pharmaceuticals	USD 268M		22M	2026-06
IQVIA Holdings	USD 4.37B		220M	2026-06
Laboratorios Farma	EUR 448.66M		67.82M	2023-12
Moderna	USD 100M		289M	2026-06
Organon & Co	USD 1.56B		100M	2026-06
Pharma Mar	EUR 50M		7.1M	2026-06
Revvity	USD 729.68M		18.68M	2026-06
Tectonic Therapeutic	USD 0		0	2024-12
Viatris	USD 3.76B		240M	2026-06
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03